Cidara Therapeutics, Inc.

NORTHERN TRUST CORP

Report date

3/31/2024

Quarter

2024 Q1

Filed

5/14/2024

Shares

160,356

Value ($000)

148

Weight

0.0%

2019 Q4 - 2024 Q1 (18 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2024 Q1	5/14/2024	148	0.0%	160,356	3/31/2024
2023 Q4	2/13/2024	127	0.0%	160,574	12/31/2023
2023 Q3	11/13/2023	121	0.0%	127,965	9/30/2023
2023 Q2	8/11/2023	145	0.0%	127,965	6/30/2023
2023 Q1	5/15/2023	142	0.0%	111,941	3/31/2023
2022 Q4	2/13/2023	80	0.0%	105,490	12/31/2022
2022 Q3	11/14/2022	66	0.0%	105,490	9/30/2022
2022 Q2	8/12/2022	48	0.0%	98,393	6/30/2022
2022 Q1	5/13/2022	82	0.0%	98,393	3/31/2022
2021 Q4	2/8/2022	140	0.0%	110,497	12/31/2021
2021 Q3	11/15/2021	156	0.0%	69,722	9/30/2021
2021 Q2	8/13/2021	146	0.0%	72,428	6/30/2021
2021 Q1	5/12/2021	996	0.0%	374,406	3/31/2021
2020 Q4	2/11/2021	780	0.0%	390,018	12/31/2020
2020 Q3	11/16/2020	1,097	0.0%	384,937	9/30/2020
2020 Q2	8/14/2020	436	0.0%	118,014	6/30/2020
2020 Q1	5/14/2020	120	0.0%	48,423	3/31/2020
2019 Q4	2/14/2020	112	0.0%	29,236	12/31/2019